{"AllianceGenome": "2207", "HGNC": "2207", "MIM": "303630", "_id": "1287", "_version": 2, "accession": {"genomic": ["AB839033.1", "AB839034.1", "AB839035.1", "AH002550.2", "AH006316.3", "AL031622.1", "AL034369.1", "AL035425.13", "AL136364.7", "CH471120.2", "CP068255.2", "KF459303.1", "NC_000023.11", "NC_060947.1", "NG_011977.2", "S71779.1", "S75903.1", "X71745.1", "Z37153.1"], "protein": ["AAA51558.1", "AAA52045.1", "AAA52046.1", "AAA99480.1", "AAB31853.2", "AAB33374.1", "AAC27816.1", "AAC60612.1", "AAD13909.1", "AAF66217.2", "AAH35387.1", "AAI51847.1", "AIW39922.1", "BAG57411.1", "CAA85512.1", "EAX02683.1", "EAX02684.1", "EAX02685.1", "EAX02686.1", "NP_000486.1", "NP_203699.1", "P29400.2", "WCO04973.1", "WCO04974.1", "WCO04975.1", "XP_011529151.2", "XP_016884748.1", "XP_016884749.1", "XP_016884750.1", "XP_016884751.1", "XP_047297766.1", "XP_047297767.1", "XP_054182410.1", "XP_054182411.1", "XP_054182412.1", "XP_054182413.1", "XP_054182414.1", "XP_054182415.1", "XP_054182416.1"], "rna": ["AK294066.1", "AK307900.1", "AK311302.1", "BC035387.1", "BC151846.1", "BU688037.1", "BX641049.1", "DA461056.1", "KM282618.1", "M31115.1", "M58526.1", "M90464.1", "NM_000495.5", "NM_033380.3", "NM_033381.1", "ON364107.1", "ON381715.1", "ON381716.1", "ON381717.1", "ON381718.1", "ON381719.1", "PP412809.1", "PP412810.1", "S59334.1", "S69168.1", "XM_011530849.3", "XM_017029259.3", "XM_017029260.2", "XM_017029261.2", "XM_017029262.3", "XM_047441810.1", "XM_047441811.1", "XM_054326435.1", "XM_054326436.1", "XM_054326437.1", "XM_054326438.1", "XM_054326439.1", "XM_054326440.1", "XM_054326441.1"], "translation": [{"protein": "XP_054182411.1", "rna": "XM_054326436.1"}, {"protein": "AAA52045.1", "rna": "M31115.1"}, {"protein": "AAA99480.1", "rna": "M58526.1"}, {"protein": "XP_011529151.2", "rna": "XM_011530849.3"}, {"protein": "NP_203699.1", "rna": "NM_033380.3"}, {"protein": "XP_054182413.1", "rna": "XM_054326438.1"}, {"protein": "AIW39922.1", "rna": "KM282618.1"}, {"protein": "XP_016884748.1", "rna": "XM_017029259.3"}, {"protein": "WCO04973.1", "rna": "ON381715.1"}, {"protein": "WCO04974.1", "rna": "ON381717.1"}, {"protein": "XP_016884749.1", "rna": "XM_017029260.2"}, {"protein": "AAH35387.1", "rna": "BC035387.1"}, {"protein": "XP_047297767.1", "rna": "XM_047441811.1"}, {"protein": "XP_016884750.1", "rna": "XM_017029261.2"}, {"protein": "AAI51847.1", "rna": "BC151846.1"}, {"protein": "XP_054182415.1", "rna": "XM_054326440.1"}, {"protein": "XP_054182410.1", "rna": "XM_054326435.1"}, {"protein": "AAC60612.1", "rna": "S69168.1"}, {"protein": "XP_054182416.1", "rna": "XM_054326441.1"}, {"protein": "XP_016884751.1", "rna": "XM_017029262.3"}, {"protein": "WCO04975.1", "rna": "ON381718.1"}, {"protein": "AAD13909.1", "rna": "S59334.1"}, {"protein": "AAA52046.1", "rna": "M90464.1"}, {"protein": "BAG57411.1", "rna": "AK294066.1"}, {"protein": "XP_054182414.1", "rna": "XM_054326439.1"}, {"protein": "XP_047297766.1", "rna": "XM_047441810.1"}, {"protein": "NP_000486.1", "rna": "NM_000495.5"}, {"protein": "XP_054182412.1", "rna": "XM_054326437.1"}]}, "alias": ["ASLN", "ATS", "ATS1", "CA54"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2019-03-19T16:00:00.000Z", "disease_label": "Alport syndrome", "gcep": "Hearing Loss Gene Curation Expert Panel", "moi": "XL", "mondo": "MONDO:0018965", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0407dc2e-1cab-4043-889d-4695b043d7b3-2019-03-19T160000.000Z", "sop": "SOP6"}}, "ensembl": {"gene": "ENSG00000188153", "protein": ["ENSP00000331902", "ENSP00000354505", "ENSP00000423520", "ENSP00000424137", "ENSP00000424845", "ENSP00000495101", "ENSP00000495685"], "transcript": ["ENST00000328300", "ENST00000361603", "ENST00000470339", "ENST00000477429", "ENST00000483338", "ENST00000489230", "ENST00000504541", "ENST00000505728", "ENST00000510690", "ENST00000515658", "ENST00000642185", "ENST00000644079"], "translation": [{"protein": "ENSP00000331902", "rna": "ENST00000328300"}, {"protein": "ENSP00000354505", "rna": "ENST00000361603"}, {"protein": "ENSP00000495101", "rna": "ENST00000642185"}, {"protein": "ENSP00000495685", "rna": "ENST00000483338"}, {"protein": "ENSP00000424137", "rna": "ENST00000505728"}, {"protein": "ENSP00000423520", "rna": "ENST00000515658"}, {"protein": "ENSP00000424845", "rna": "ENST00000504541"}], "type_of_gene": "protein_coding"}, "entrezgene": "1287", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 48.4872597434, "exp_mis": 333.987624519, "exp_syn": 139.935002191, "lof_z": 6.1863988998709, "mis_z": 1.2575769421799, "mu_lof": 4.18323178264e-06, "mu_mis": 4.37164276236e-05, "mu_syn": 1.69428330951e-05, "n_lof": 5.0, "n_mis": 287.0, "n_syn": 138.0, "p_li": 0.999918348283007, "p_null": 8.01978082453147e-15, "p_rec": 8.16517169853827e-05, "syn_z": 0.101406846625109}, "bp": 5076, "cds_end": 107939608, "cds_start": 107683355, "n_exons": 53, "nonpsych": {"exp_lof": 43.2271176624, "exp_mis": 302.18790396, "exp_syn": 126.174051532, "lof_z": 6.15824259441894, "mis_z": 1.54324888451838, "mu_lof": 4.18323178264e-06, "mu_mis": 4.37164276236e-05, "mu_syn": 1.69428330951e-05, "n_lof": 2.0, "n_mis": 249.0, "n_syn": 126.0, "p_li": 0.999996378559975, "p_null": 5.97218901191517e-16, "p_rec": 3.62144002456353e-06, "syn_z": 0.00975836633226832}, "nontcga": {"exp_lof": 43.9077587199, "exp_mis": 303.937808852, "exp_syn": 127.197184777, "lof_z": 5.7922433899341, "mis_z": 1.34134430832046, "mu_lof": 4.18323178264e-06, "mu_mis": 4.37164276236e-05, "mu_syn": 1.69428330951e-05, "n_lof": 5.0, "n_mis": 257.0, "n_syn": 126.0, "p_li": 0.999565547543353, "p_null": 4.69749401744946e-13, "p_rec": 0.000434452456176809, "syn_z": 0.0672125155535626}, "transcript": "ENST00000328300.6"}, "exons": [{"cdsend": 108696378, "cdsstart": 108440125, "chr": "X", "position": [[108439837, 108440206], [108539745, 108539805], [108559063, 108559153], [108563881, 108563926], [108568628, 108568673], [108568758, 108568821], [108571412, 108571466], [108571810, 108571837], [108573573, 108573654], [108575909, 108575972], [108577951, 108577987], [108578077, 108578119], [108578290, 108578383], [108580532, 108580586], [108580681, 108580738], [108580982, 108581027], [108582883, 108582937], [108584483, 108584525], [108586614, 108586747], [108591057, 108591231], [108591560, 108591644], [108595508, 108595601], [108596997, 108597068], [108597376, 108597568], [108598701, 108598870], [108601392, 108601485], [108601884, 108601989], [108602963, 108603061], [108606741, 108606892], [108614910, 108615024], [108620258, 108620426], [108621802, 108621892], [108622675, 108622825], [108624235, 108624334], [108625704, 108625794], [108626209, 108626349], [108655330, 108655457], [108665506, 108665587], [108666495, 108666594], [108667132, 108667183], [108668318, 108668504], [108677499, 108677633], [108680678, 108680751], [108680884, 108680956], [108681759, 108681888], [108686030, 108686129], [108687481, 108687694], [108692747, 108692925], [108694806, 108694921], [108695266, 108695439], [108696296, 108697545]], "strand": 1, "transcript": "NM_000495", "txend": 108697545, "txstart": 108439837}, {"cdsend": 108696378, "cdsstart": 108440125, "chr": "X", "position": [[108439837, 108440206], [108539745, 108539805], [108559063, 108559153], [108563881, 108563926], [108568628, 108568673], [108568758, 108568821], [108571412, 108571466], [108571810, 108571837], [108573573, 108573654], [108575909, 108575972], [108577951, 108577987], [108578077, 108578119], [108578290, 108578383], [108580532, 108580586], [108580681, 108580738], [108580982, 108581027], [108582883, 108582937], [108584483, 108584525], [108586614, 108586747], [108591057, 108591231], [108591560, 108591644], [108595508, 108595601], [108596997, 108597068], [108597376, 108597568], [108598701, 108598870], [108601392, 108601485], [108601884, 108601989], [108602963, 108603061], [108606741, 108606892], [108614910, 108615024], [108620258, 108620426], [108621802, 108621892], [108622675, 108622825], [108624235, 108624334], [108625704, 108625794], [108626209, 108626349], [108655330, 108655457], [108665506, 108665587], [108666495, 108666594], [108667132, 108667183], [108668318, 108668506], [108677496, 108677633], [108680678, 108680751], [108680884, 108680956], [108681759, 108681888], [108686030, 108686129], [108687481, 108687694], [108692747, 108692925], [108694806, 108694921], [108695266, 108695439], [108696296, 108697545]], "strand": 1, "transcript": "NM_033380", "txend": 108697545, "txstart": 108439837}], "exons_hg19": [{"cdsend": 107939608, "cdsstart": 107683355, "chr": "X", "position": [[107683067, 107683436], [107782975, 107783035], [107802293, 107802383], [107807111, 107807156], [107811858, 107811903], [107811988, 107812051], [107814642, 107814696], [107815040, 107815067], [107816803, 107816884], [107819139, 107819202], [107821181, 107821217], [107821307, 107821349], [107821520, 107821613], [107823762, 107823816], [107823911, 107823968], [107824212, 107824257], [107826113, 107826167], [107827713, 107827755], [107829844, 107829977], [107834287, 107834461], [107834790, 107834874], [107838738, 107838831], [107840227, 107840298], [107840606, 107840798], [107841931, 107842100], [107844622, 107844715], [107845114, 107845219], [107846193, 107846291], [107849971, 107850122], [107858140, 107858254], [107863488, 107863656], [107865032, 107865122], [107865905, 107866055], [107867465, 107867564], [107868934, 107869024], [107869439, 107869579], [107898560, 107898687], [107908736, 107908817], [107909725, 107909824], [107910362, 107910413], [107911548, 107911734], [107920729, 107920863], [107923908, 107923981], [107924114, 107924186], [107924989, 107925118], [107929260, 107929359], [107930711, 107930924], [107935977, 107936155], [107938036, 107938151], [107938496, 107938669], [107939526, 107940775]], "strand": 1, "transcript": "NM_000495", "txend": 107940775, "txstart": 107683067}, {"cdsend": 107939608, "cdsstart": 107683355, "chr": "X", "position": [[107683067, 107683436], [107782975, 107783035], [107802293, 107802383], [107807111, 107807156], [107811858, 107811903], [107811988, 107812051], [107814642, 107814696], [107815040, 107815067], [107816803, 107816884], [107819139, 107819202], [107821181, 107821217], [107821307, 107821349], [107821520, 107821613], [107823762, 107823816], [107823911, 107823968], [107824212, 107824257], [107826113, 107826167], [107827713, 107827755], [107829844, 107829977], [107834287, 107834461], [107834790, 107834874], [107838738, 107838831], [107840227, 107840298], [107840606, 107840798], [107841931, 107842100], [107844622, 107844715], [107845114, 107845219], [107846193, 107846291], [107849971, 107850122], [107858140, 107858254], [107863488, 107863656], [107865032, 107865122], [107865905, 107866055], [107867465, 107867564], [107868934, 107869024], [107869439, 107869579], [107898560, 107898687], [107908736, 107908817], [107909725, 107909824], [107910362, 107910413], [107911548, 107911736], [107920726, 107920863], [107923908, 107923981], [107924114, 107924186], [107924989, 107925118], [107929260, 107929359], [107930711, 107930924], [107935977, 107936155], [107938036, 107938151], [107938496, 107938669], [107939526, 107940775]], "strand": 1, "transcript": "NM_033380", "txend": 107940775, "txstart": 107683067}], "generif": [{"pubmed": 11051113, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11462238, "text": "SSCP analysis in X-linked Alport syndrome"}, {"pubmed": 11961405, "text": "new point mutation in a Spanish family with X-linked Alport syndrome"}, {"pubmed": 12021518, "text": "an imbalance of glomerular alpha2(IV) and alpha5(IV) chain expression occurred in IgA nephropathy"}, {"pubmed": 12105244, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12218303, "text": "thin basement membrane disease might be caused by an abnormality of the alpha5(IV) antigen along the glomerular basement membrane"}, {"pubmed": 12478350, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12732331, "text": "human CA54 protein has a natural tendency towards variants"}, {"pubmed": 12796257, "text": "This study showed abnormal composition of alpha(IV) chains in the anterior lens capsule of a patient with anterior lenticonus caused by a nonsense mutation in the COL4A5 gene."}, {"pubmed": 14514738, "text": "absence of genotype-phenotype correlation and the large intrafamilial phenotypic heterogeneity"}, {"pubmed": 14531812, "text": "there is no correlation between the severity of the glomerular involvement (expressed by proteinuria) and the staining of the alpha 5 chain in the EBM in females with X-linked Alport syndrome."}, {"pubmed": 14592452, "text": "We provide a first indication that highly specialized patterns characteristic of COL4A5-COL4A6 expression in vivo arise from effects of distributed cis-acting regulatory elements on a bidirectional proximal promoter, itself transcriptionally competent."}, {"pubmed": 14993485, "text": "critical role of COL4A5 gene mutations in the pathogenesis of Alport's syndrome."}, {"pubmed": 15149316, "text": "Alport syndrome in French Polynesia is due to a founder mutation, a tandem duplication of 35 exons, that occurred onto a common haplotype"}, {"pubmed": 15211113, "text": "Collagen chains alpha5(IV) and alpha6(IV) were frequently absent in basement membrane from pancreatic adenocarcinoma, and their absence might be related to the invasion of cancer cells."}, {"pubmed": 15365990, "text": "The predicted rates of AA substitutions for glycine were compared with missense mutations that have been observed to cause disease. Any Gly replacement will cause disease & the level of triple-helix destabilization determines clinical outcome."}, {"pubmed": 15583824, "text": "distinctive patterns of expression of the alpha1 (IV) and alpha5 (IV) collagen chains may be related to the histogenic sudoral origin of cyli"}, {"pubmed": 15780079, "text": "COL4A5 mutations observed in evident X-linked Alport syndrome using genomic DNA."}, {"pubmed": 15954103, "text": "novel mutations identified during routine molecular diagnostics for Alport syndrome"}, {"pubmed": 16284948, "text": "both COL12A1 and COL4A5 constitute good candidate target genes in the pathogenesis of subungual exostosis"}, {"pubmed": 16507901, "text": "The expression of the alpha5(IV)/alpha6(IV) chains was down-regulated in colorectal cancer, and the loss of expression of the alpha5(IV)/alpha6(IV) chains was associated with the hypermethylation of their promoter region."}, {"pubmed": 16613845, "text": "analysis of conformational features of a natural break in the type IV collagen Gly-X-Y repeat"}, {"pubmed": 16940319, "text": "Immunolocalization of alpha5 type (IV)-chain collagen in the kidney may correspond to the severity of the clinical phenotype."}, {"pubmed": 16941480, "text": "Twenty-one mutations in COL4A5 gene were identified in patients with Alport syndrome and they include four gross deletions, two deep intronic mutations, three frameshifts, three splice site mutations, eight missense mutations and one inframe deletion."}, {"pubmed": 17277342, "text": "The cysteine to tyrosine substitution in the NC1 domain of the alpha5(IV) collagen chain in this family leads to a mild form of Alport syndrome, including absence of extra-renal features."}, {"pubmed": 17294221, "text": "Ultrastructure of COL4A5 immunofluorescence staining of the glomerular basement membrane and Bowman capsule was demonstrated.  In conrast, this protein was absent in the basement membrane of skin cells."}, {"pubmed": 17396119, "text": "16 novel mutations identified in COL4A3, COL4A4 & COL4A5 genes in Slovenian families with Alport syndrome(ATS)& benign familial hematuria; 12 mutations found in COL4A5 gene in ATS patients (9 missense, 1 splice site, 1 frameshift & 1 nonsense mutation)"}, {"pubmed": 17554254, "text": "Comparison of alpha5(IV) with alpha2(IV) expression in Alport patients is simple and eliminates technical artifacts."}, {"pubmed": 18083113, "text": "These findings indicate that a defect in heterotrimer formation is the main molecular mechanism underlying the pathogenesis of AS caused by mutation in the NC1 domain."}, {"pubmed": 18616531, "text": "combination of cDNA and MLPA analysis improves the mutation detection rate in COL4A5 and that MLPA should be the first step in genetic testing for X-linked AS"}, {"pubmed": 18706356, "text": "The co-detection of alpha5 and alpha2 chains of collagen IV in frozen skin biopsies is therefore proposed as a simple technique to diagnose Alport syndrome."}, {"pubmed": 18930919, "text": "analysis of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen"}, {"pubmed": 19065523, "text": "a novel splicing mutation of c.1517-1G to T in the COL4A5 gene causing Alport syndrome in a Chinese family"}, {"pubmed": 19281745, "text": "study reports on a family with atypical Alport disease initially presenting as hereditary focal and segmental glomerulosclerosis; a previously undescribed COL4A5 mutation was identified as cause of the disease"}, {"pubmed": 19610672, "text": "Aromatic residues greatly accelerate the kinetics of self-association in a typical sequence from the alpha5 chain of type IV collagen, decreasing lag time and leading to insoluble, well-defined linear fibrils as well as small soluble aggregates."}, {"pubmed": 19728970, "text": "underlying COL4A5 (collagen type IV alpha 5) mutation, truncating or non-truncating, can significantly predict the age at End stage renal disease in male patients"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19919694, "text": "An assay useful for mutations responsible for the most adult type Alport syndrome in the U.S. is recommended for testing individuals from families carrying one of the COL4A5 mutations tested: Cys1564Ser, Leu1649Arg or Arg1677Gln."}, {"pubmed": 19965530, "text": "Severe mutations in male individuals with X-linked Alport syndrome are associated with the perimacular dot-and-fleck retinopathy. Furthermore, the retinopathy indicates that male individuals are at increased risk for renal failure before the age of 30"}, {"pubmed": 20378821, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20378821, "text": "younger age at onset of ESRD associated with mutations at the 5' end of the gene"}, {"pubmed": 20452482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20574986, "text": "A curated disease-specific database containing reported sequence variants in COL4A5, was developed."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20673868, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20881942, "text": "A novel COL4A5 mutation causes rapid progression to end-stage renal disease in males, despite the absence of clinical and biopsy findings associated with Alport syndrome."}, {"pubmed": 20951201, "text": "expression of collagen type IV alpha5 chain in the smooth muscle BM of the gastrointestinal tract is restricted to the esophagus in humans"}, {"pubmed": 21143337, "text": "Identified mutations of the COL4A5 and COL4A3 gene in five Chinese Alport syndrome families."}, {"pubmed": 21187648, "text": "Overexpression of HSP47 decreased the secretion of heterotrimers containing the mutant collagen alpha5(IV) chain."}, {"pubmed": 21332469, "text": "Certain mutations within the COL4A5 gene are associated with heterogeneous phenotypes."}, {"pubmed": 21380622, "text": "In this paper we improve the definition of the COL4A5/COL4A6 deletions in three Alport syndrome with diffuse leiomyomatosis."}, {"pubmed": 21848006, "text": "Mutation analysis of the proband has revealed a novel nonsense mutation (c.1135C>T; Gln379X) in exon 19 of the COL4A5 gene which may lead to a more severe phenotype in affected family members. carrying this mutation"}, {"pubmed": 22335431, "text": "Genotype-phenotype correlation in X-linked Alport syndrome patients carrying missense mutations in the collagenous domain of COL4A5"}, {"pubmed": 22919268, "text": "A novel COL4A5 mutation (g. 4400_4400+1del), was detected in a Chinese female patient with X-linked Alport syndrome and her son."}, {"pubmed": 23085274, "text": "report for the first time revealed that the frameshift mutation in the type IV collagen chain alpha5 causes only renal disease, without extrarenal lesion."}, {"pubmed": 23551189, "text": "The expression of collagen type IV and its alpha chains (alpha1-6) was investigated in different endothelial cell culture systems in vitro qualitatively and quantitatively."}, {"pubmed": 24033287, "text": "31 mutation in COL4A5 associated with autosomal dominant Alport syndrome."}, {"pubmed": 24043717, "text": "The objective of the following study was to record the specificity and sensitivity of alpha5(IV) loss, smoothelin expression and PLAP expression as markers of gastrointestinal smooth muscle neoplasms"}, {"pubmed": 24304881, "text": "Results help to clarify the milder clinical manifestations and molecular characteristics of male X-linked Alport syndrome patients expressing the alpha5(IV) chain."}, {"pubmed": 24337245, "text": "Case Report: female with X-linked Alport syndrome with compound heterozygous COL4A5 mutations and germ cell mosaicism."}, {"pubmed": 24522658, "text": "A novel missense mutation c.368G>A (p.Gly123Glu) in the collagen type IV alpha-5 gene (COL4A5) was found to be the genetic cause of the Alport syndrome"}, {"pubmed": 25110662, "text": "These results broadens the mutation spectrum in the COL4A5 gene associated with Alport syndrome."}, {"pubmed": 25183659, "text": "we report 10 intronic mutations and one exonic mutation that produce aberrant splicing, including four deep intronic mutations that produced cryptic exons."}, {"pubmed": 25307721, "text": "New COL4A5 mutations among Portuguese patients with collagen IV-related nephropathies were identified in unrelated individuals."}, {"pubmed": 25572247, "text": "We identified a nucleotide change 1226 G>A, causing amino acid substitutions of Gly to Asp at position 409, in hemizygosis in the exon 20 of COL4A5 gene (proband 16 and the 13 in Alport syndrome pedigree"}, {"pubmed": 25575550, "text": "we identified seven families with associated mutations in COL4A3 and COL4A4 genes and four families with associated mutations in COL4A4 and COL4A5. We did not find kindreds with digenic inheritance attributable to mutations in COL4A3 and COL4A5"}, {"pubmed": 25633161, "text": "Case Report: subepidermal blistering disease with autoantibodies to multiple laminin subunits which developed autoantibodies to COL4A5 associated with membranous glomerulonephropathy."}, {"pubmed": 25739341, "text": "Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease."}, {"pubmed": 25840998, "text": "the intima+media of IPAH vessels, collagens (COL4A5, COL14A1, and COL18A1), matrix metalloproteinase (MMP) 19, and a disintegrin and metalloprotease (ADAM) 33 were higher expressed, whereas MMP10, ADAM17, TIMP1, and TIMP3 were less abundant."}, {"pubmed": 25992553, "text": "alpha5(IV), but not alpha1(IV), promotes lung cancer cell proliferation and tumor angiogenesis through non-integrin collagen receptor DDR1-mediated ERK activation."}, {"pubmed": 26179878, "text": "New deletion in COL4A6/COL4A5 related to diffuse esophageal leiomyomatosis associated with Alport syndrome in a Chinese family."}, {"pubmed": 26346198, "text": "We show that collagen IV mutations, including COL4A5, frequently underlie FSGS and should be considered, particularly with a positive family history. Targeted NGS improves diagnostic efficiency by investigating many candidate genes in parallel."}, {"pubmed": 26581810, "text": "Synonymous COL4A5 substitution responsible for X-linked Alport syndrome."}, {"pubmed": 26866448, "text": "Sanger sequencing of these regions identified a novel splicesite mutation in intron 9 (c.547-3C>A) of the COL4A5 gene. Subsequent cDNA analysis revealed that c.547- 3C>A led to skipping of exon 10, which resulted in an in-frame deletion of 21 amino acids from the a5 chain of type IV collagen.  This is the first report of the novel c.547-3C>A splicing mutation in the collagen domain of COL4A5 gene."}, {"pubmed": 27377778, "text": "although alpha5 and alpha6 (IV) chains are induced in the glomerular basement membrane in autosomal recessive Alport syndrome, their induction does not seem to play a major compensatory role"}, {"pubmed": 27576055, "text": "Alport syndrome is the result of mutations in any of three type IV collagen genes, COL4A3, COL4A4, or COL4A5. Because the three collagen chains form heterotrimers, there is an absence of all three proteins in the basement membranes where they are expressed. (Review)"}, {"pubmed": 27796712, "text": "Case Reports: female X-linked Alport syndrome patients with somatic mosaic variants in COL4A5. Phenotype severity in females could be affected by modifier gene variants."}, {"pubmed": 27859054, "text": "Two families showed COL4A3/A4 mutations in cis, mimicking an autosomal dominant inheritance with a more severe phenotype and one showed COL4A3/A4 mutations in trans, mimicking an autosomal recessive inheritance with a less severe phenotype. In a fourth family, a de novo mutation (COL4A5) combined with an inherited mutation (COL4A3) triggered a more severe phenotype"}, {"pubmed": 28275241, "text": "deletion breakpoints in five Alport syndrome-diffuse leiomyomatosis patients and show a contiguous COL4A6/COL4A5 deletion in each case, were characterized."}, {"pubmed": 28542346, "text": "mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome"}, {"pubmed": 28604958, "text": "Missense mutation in exon 28 of the COL4A5 gene is associated with focal segmental glomerulosclerosis."}, {"pubmed": 28632965, "text": "COL4A mutations comprise a frequent cause of Familial microscopic hematuria."}, {"pubmed": 28704582, "text": "COL4A3/A4/A5 mutations were found in aconsiderable fraction of patients with hereditary nephritis that is difficult to diagnose clinicopathologically."}, {"pubmed": 28827396, "text": "variant c.2858G>T, rs78972735, annotated as a pathogenic mutation in dbSNP and human gene mutation database (HGMD), found in four family members with no clinical traits of Alport syndrome"}, {"pubmed": 30293132, "text": "heterozygous mutation (NM_000495.4: exon41:c.C3769T: p.Q1257X) associated with X-linked Alport syndrome"}, {"pubmed": 30647093, "text": "Even with an expanded gene panel, we find that COL4A disorders are the leading monogenic cause in adults diagnosed with FSGS."}, {"pubmed": 30661074, "text": "segregation analysis raises the possibility that Alport syndrome resembles also digenic inheritance by COL4A3/COL4A5"}, {"pubmed": 30691124, "text": "Results found that in addition to mutations in COL4A5 type IV collagen gene, nephrin and podocin polymorphisms aggravated kidney damage, leading to focal segmental glomerulosclerosis (FSGS) with ruptures of the basement membrane and early renal failure. This study suggests a synergistic role for genes encoding basement membrane and slit diaphragm proteins as a cause of kidney injury due to FSGS."}, {"pubmed": 31209800, "text": "Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome. We identified a novel hemizygous single nucleotide deletion c.1902delA in COL4A5 gene"}, {"pubmed": 31481700, "text": "Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay."}, {"pubmed": 31490752, "text": "A COL4A5 Missense Variant in a Han-Chinese Family with X-linked Alport Syndrome."}, {"pubmed": 31576025, "text": "Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families."}, {"pubmed": 31901041, "text": "Two heterozygous splice site mutations of COL4A5 gene c.2147-2A > T (IVS27) and c.646-2A > G (IVS11) (NM_033380) were found in patients of the two families, which showed a co-segregation association with the affected members of the families"}, {"pubmed": 32543079, "text": "Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay."}, {"pubmed": 32659759, "text": "Comparative Functional Analysis in vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families."}, {"pubmed": 32761583, "text": "[Identification of a novel variant of COL4A5 gene in a pedigree affected with Alport syndrome]."}, {"pubmed": 32812400, "text": "Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome."}, {"pubmed": 33040356, "text": "Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial."}, {"pubmed": 33087535, "text": "New COL4A5 mutation in IgA nephropathy."}, {"pubmed": 33144651, "text": "Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5."}, {"pubmed": 33309955, "text": "Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife."}, {"pubmed": 33748275, "text": "Novel Mutations of COL4A5 Identified in Chinese Families with X-Linked Alport Syndrome and Literature Review."}, {"pubmed": 33974256, "text": "[Genetic and clinical analysis of a pedigree affected with X-linked dominant Alport syndrome due to a novel variant of COL4A5 gene]."}, {"pubmed": 34400539, "text": "Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome."}, {"pubmed": 34930753, "text": "Guidelines for Genetic Testing and Management of Alport Syndrome."}, {"pubmed": 35020912, "text": "Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome."}, {"pubmed": 35022790, "text": "Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study."}, {"pubmed": 35177655, "text": "Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome."}, {"pubmed": 35789182, "text": "Pathogenicity of missense variants affecting the collagen IV alpha5 carboxy non-collagenous domain in X-linked Alport syndrome."}, {"pubmed": 36130833, "text": "Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients."}, {"pubmed": 36371577, "text": "Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene."}, {"pubmed": 36484686, "text": "Type IV collagen alpha5 chain promotes luminal breast cancer progression through c-Myc-driven glycolysis."}, {"pubmed": 37402896, "text": "Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence."}, {"pubmed": 37596645, "text": "Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome."}, {"pubmed": 37906141, "text": "[Genetic testing and prenatal diagnosis for two Chinese pedigrees affected with Alport syndrome due to variants of COL4A5 gene]."}, {"pubmed": 38400605, "text": "Three exonic variants in the COL4A5 gene alter RNA splicing in a minigene assay."}, {"pubmed": 38433557, "text": "Genetic diagnosis of Alport syndrome in 16 Chinese families."}, {"pubmed": 38671472, "text": "A novel COL4A5 splicing mutation causes alport syndrome in a Chinese family."}, {"pubmed": 38978054, "text": "Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome."}], "genomic_pos": {"chr": "X", "end": 108697545, "ensemblgene": "ENSG00000188153", "start": 108439838, "strand": 1}, "genomic_pos_hg19": {"chr": "X", "end": 107940775, "start": 107683074, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0007528", "qualifier": "involved_in", "term": "neuromuscular junction development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030198", "qualifier": "involved_in", "term": "extracellular matrix organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0038063", "qualifier": "involved_in", "term": "collagen-activated tyrosine kinase receptor signaling pathway"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005587", "qualifier": "part_of", "term": "collagen type IV trimer"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005604", "qualifier": "is_active_in", "term": "basement membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005788", "qualifier": "located_in", "term": "endoplasmic reticulum lumen"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0031594", "qualifier": "located_in", "term": "neuromuscular junction"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0062023", "pubmed": [28344315, 28675934], "qualifier": "located_in", "term": "collagen-containing extracellular matrix"}], "MF": [{"category": "MF", "evidence": "HDA", "id": "GO:0030020", "pubmed": 28344315, "qualifier": "enables", "term": "extracellular matrix structural constituent conferring tensile strength"}, {"category": "MF", "evidence": "IBA", "id": "GO:0030020", "qualifier": "enables", "term": "extracellular matrix structural constituent conferring tensile strength"}, {"category": "MF", "evidence": "RCA", "id": "GO:0030020", "pubmed": 28675934, "qualifier": "enables", "term": "extracellular matrix structural constituent conferring tensile strength"}]}, "homologene": {"genes": [[9598, 465805], [9606, 1287], [10090, 12830]], "id": 133559}, "interpro": [{"desc": "Collagen IV, non-collagenous", "id": "IPR001442", "short_desc": "Collagen_IV_NC"}, {"desc": "Collagen triple helix repeat", "id": "IPR008160", "short_desc": "Collagen"}, {"desc": "C-type lectin fold", "id": "IPR016187", "short_desc": "CTDL_fold"}, {"desc": "Collagen IV, non-collagenous domain superfamily", "id": "IPR036954", "short_desc": "Collagen_IV_NC_sf"}], "ipi": ["IPI00021715", "IPI00216007"], "map_location": "Xq22.3", "name": "collagen type IV alpha 5 chain", "other_names": ["collagen IV, alpha-5 polypeptide", "collagen alpha-5(IV) chain", "collagen of basement membrane, alpha-5 chain", "collagen, type IV, alpha 5", "dA149D17.3", "dA24A23.1"], "pantherdb": {"HGNC": "2207", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88456", "ortholog_type": "LDO", "panther_family": "PTHR24023", "taxid": 10090, "uniprot_kb": "Q63ZW6"}, {"RGD": "1565499", "ortholog_type": "LDO", "panther_family": "PTHR24023", "taxid": 10116, "uniprot_kb": "F1LUN5"}, {"ZFIN": "ZDB-GENE-030131-2281", "ortholog_type": "LDO", "panther_family": "PTHR24023", "taxid": 7955, "uniprot_kb": "B0UXF7"}, {"WormBase": "WBGene00001263", "ortholog_type": "LDO", "panther_family": "PTHR24023", "taxid": 6239, "uniprot_kb": "P17139"}], "uniprot_kb": "P29400"}, "pathway": {"biocarta": [{"id": "intrinsicpathway", "name": "intrinsic prothrombin activation pathway"}, {"id": "npp1pathway", "name": "regulators of bone mineralization"}], "kegg": [{"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04510", "name": "Focal adhesion - Homo sapiens (human)"}, {"id": "hsa04512", "name": "ECM-receptor interaction - Homo sapiens (human)"}, {"id": "hsa04926", "name": "Relaxin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04933", "name": "AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human)"}, {"id": "hsa04974", "name": "Protein digestion and absorption - Homo sapiens (human)"}, {"id": "hsa05146", "name": "Amoebiasis - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05222", "name": "Small cell lung cancer - Homo sapiens (human)"}], "pid": [{"id": "avb3_integrin_pathway", "name": "Integrins in angiogenesis"}, {"id": "integrin1_pathway", "name": "Beta1 integrin cell surface interactions"}, {"id": "integrin3_pathway", "name": "Beta3 integrin cell surface interactions"}, {"id": "syndecan_1_pathway", "name": "Syndecan-1-mediated signaling events"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1442490", "name": "Collagen degradation"}, {"id": "R-HSA-1442490", "name": "Collagen degradation"}, {"id": "R-HSA-1474228", "name": "Degradation of the extracellular matrix"}, {"id": "R-HSA-1474228", "name": "Degradation of the extracellular matrix"}, {"id": "R-HSA-1474244", "name": "Extracellular matrix organization"}, {"id": "R-HSA-1474244", "name": "Extracellular matrix organization"}, {"id": "R-HSA-1474290", "name": "Collagen formation"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1650814", "name": "Collagen biosynthesis and modifying enzymes"}, {"id": "R-HSA-186797", "name": "Signaling by PDGF"}, {"id": "R-HSA-2022090", "name": "Assembly of collagen fibrils and other multimeric structures"}, {"id": "R-HSA-216083", "name": "Integrin cell surface interactions"}, {"id": "R-HSA-216083", "name": "Integrin cell surface interactions"}, {"id": "R-HSA-2214320", "name": "Anchoring fibril formation"}, {"id": "R-HSA-2243919", "name": "Crosslinking of collagen fibrils"}, {"id": "R-HSA-3000157", "name": "Laminin interactions"}, {"id": "R-HSA-3000157", "name": "Laminin interactions"}, {"id": "R-HSA-3000171", "name": "Non-integrin membrane-ECM interactions"}, {"id": "R-HSA-3000178", "name": "ECM proteoglycans"}, {"id": "R-HSA-375165", "name": "NCAM signaling for neurite out-growth"}, {"id": "R-HSA-376176", "name": "Signaling by ROBO receptors"}, {"id": "R-HSA-419037", "name": "NCAM1 interactions"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-8948216", "name": "Collagen chain trimerization"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9010553", "name": "Regulation of expression of SLITs and ROBOs"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}], "wikipathways": [{"id": "WP2572", "name": "Primary focal segmental glomerulosclerosis (FSGS)"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4658", "name": "Small cell lung cancer"}, {"id": "WP4758", "name": "Nephrotic syndrome"}]}, "pdb": ["5NAZ", "6WKU"], "pfam": ["PF01391", "PF01413"], "pharmgkb": "PA26722", "pharos": {"target_id": 17129, "tdl": "Tbio"}, "pir": "S22917", "prosite": "PS51403", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF176576", "relationship": "is"}, {"id": "GNF187482", "relationship": "is"}, {"id": "GNF198388", "relationship": "is"}, {"id": "GNF209294", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF050141", "relationship": "similar to"}, "GNF_hs-oncomine_IDT-siRNA": [{"id": "GNF281375", "relationship": "is"}, {"id": "GNF281441", "relationship": "is"}, {"id": "GNF281507", "relationship": "is"}, {"id": "GNF281573", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF338163", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095822", "relationship": "is"}, {"id": "GNF135478", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_011977.2"], "protein": ["NP_000486.1", "NP_203699.1", "XP_011529151.2", "XP_016884748.1", "XP_016884749.1", "XP_016884750.1", "XP_016884751.1", "XP_047297766.1", "XP_047297767.1", "XP_054182410.1", "XP_054182411.1", "XP_054182412.1", "XP_054182413.1", "XP_054182414.1", "XP_054182415.1", "XP_054182416.1"], "rna": ["NM_000495.5", "NM_033380.3", "NM_033381.1", "XM_011530849.3", "XM_017029259.3", "XM_017029260.2", "XM_017029261.2", "XM_017029262.3", "XM_047441810.1", "XM_047441811.1", "XM_054326435.1", "XM_054326436.1", "XM_054326437.1", "XM_054326438.1", "XM_054326439.1", "XM_054326440.1", "XM_054326441.1"], "translation": [{"protein": "XP_016884749.1", "rna": "XM_017029260.2"}, {"protein": "XP_054182411.1", "rna": "XM_054326436.1"}, {"protein": "XP_054182415.1", "rna": "XM_054326440.1"}, {"protein": "XP_054182410.1", "rna": "XM_054326435.1"}, {"protein": "XP_054182416.1", "rna": "XM_054326441.1"}, {"protein": "XP_016884751.1", "rna": "XM_017029262.3"}, {"protein": "XP_011529151.2", "rna": "XM_011530849.3"}, {"protein": "NP_203699.1", "rna": "NM_033380.3"}, {"protein": "XP_054182414.1", "rna": "XM_054326439.1"}, {"protein": "XP_054182413.1", "rna": "XM_054326438.1"}, {"protein": "XP_047297767.1", "rna": "XM_047441811.1"}, {"protein": "XP_016884750.1", "rna": "XM_017029261.2"}, {"protein": "XP_047297766.1", "rna": "XM_047441810.1"}, {"protein": "NP_000486.1", "rna": "NM_000495.5"}, {"protein": "XP_016884748.1", "rna": "XM_017029259.3"}, {"protein": "XP_054182412.1", "rna": "XM_054326437.1"}]}, "reporter": {"HG-U133_Plus_2": ["213110_s_at", "234387_at"], "HG-U95Av2": "32667_at", "HTA-2_0": ["TC0X000532.hg.1", "TC0X001822.hg.1"], "HuEx-1_0": ["3986730", "4055482"], "HuGene-1_1": "8169294", "HuGene-2_1": "17106102"}, "summary": "This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010].", "symbol": "COL4A5", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413586"}, "unigene": "Hs.369089", "uniprot": {"Swiss-Prot": "P29400", "TrEMBL": ["A7MBN3", "Q49AM6", "H0Y998", "H0Y9R8", "A0A2R8Y5W0", "H0Y9H0"]}, "wikipedia": {"url_stub": "COL4A5"}}